RENO, Nev.--A subsidiary of Accelerated Care Plus Corp. said Thursday it had finalized the purchase of Neuroflex Orthotics, Aliso Viejo, Calif. The acquisition was the first for ACP Medical Supply Corp., which was founded earlier this year to support ACP's expansion into durable medical equipment.
"One of our key initiatives for 2008 was to enter the DME market in order to provide a broader range of rehabilitation products and services to our client-partners," said ACP CEO John Beach. "We've used Neuroflex specialty orthotics in our clinical programs for over a decade and seen excellent results. Given their favorable impact on treatment outcomes, and their compatibility with our existing treatment programs, they were a natural fit for our new DME division and our core business."
The Neuroflex product line includes a range of splints, braces and appliances for the elbow, wrist, hand, finger, knee and ankle joints.
Specialty orthotic devices are used in several of ACP's specialized treatment programs, which are developed around proprietary medical technology called physical agent modalities. These devices include electrical stimulation, patterned electrical neuromuscular stimulation (PENS), therapeutic ultrasound, infrared therapy and short-wave diathermy. The company said the non-invasive, medication-free programs are developed around the needs of aging adults.
Neuroflex President John Kenny will join ACP Medical Supply Corp. as corporate orthotist. Said Kenny, "We've worked with ACP for many years and seen their presence in long-term care rehabilitation continue to grow. This is an opportunity to see our technology really hit its stride and benefit a much broader patient population."
In addition to the Neuroflex acquisition, ACP and ACP Medical Supply Corp. is planning other DME efforts including the upcoming launch of its new Omnistim FX2 Portable stimulator, a small electrical stimulation device incorporating the company's PENS technology that can be used by home patients to help manage pain and address disuse muscle atrophy.